Safe medication management in the vulnerable senior population and the avoidance of preventable medication errors during care transitions are building blocks of value-based care. Consultant pharmacists and medical directors are vital players in improving medication safety practices during these transitions to improve quality, reduce adverse drug events, prevent re-hospitalizations, and increase patient satisfaction. Join ASCP and AMDA leadership as they discuss how recent regulatory and legislative efforts affect transitions of care, how medications contribute rehospitalizations, and how a collaborative effort between the medical director, consultant pharmacist, and facility staff can avoid readmissions.
Explain how the Impact Act and Mega-Rule affect transitions of care.
Describe potential financial penalties for skilled nursing facilities that CMS will begin to assess in October of 2018.
Describe how medications contribute to the frequency of re-hospitalizations.
Discuss how pharmacists and physicians can collaborate to reduce hospital re-admissions.
MD, PhD, CMD,
Denver Veterans Affairs Medical Center
The American Society of Consultant Pharmacists
Credits: None available.
You must be logged in and own this session in order to